合計 50 件の最近のインサイダー取引記録が記録されています Aerovate Therapeutics, Inc. (AVTE), 内訳は 17 件の買い および 33 件の売り. インサイダー買い総額は $15.08M インサイダー売り総額は $3.92M.
最近活動のある主要インサイダーには Dake Benjamin T, Ra Capital Management, L.p., Eldridge George A. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — AVTE
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2024-08-01 |
Dake Benjamin T |
See Remarks |
オプション行使（売却） |
1,507 |
$1.74 |
$2.62K |
- |
| 2024-07-31 |
Dake Benjamin T |
See Remarks |
オプション行使（売却） |
10,548 |
$1.74 |
$18.35K |
1,507 |
| 2024-06-17 |
Ra Capital Management, L.p. |
10 Percent Owner |
情報に基づく買い |
928,110 |
$1.67 |
$1.55M |
7,893,678 |
| 2024-06-14 |
Eldridge George A |
See Remarks |
情報に基づく売り |
15,000 |
$25.03 |
$375.45K |
5,022 |
| 2024-06-14 |
Verwijs Marinus |
Chief Technical Officer |
情報に基づく売り |
10,600 |
$25.00 |
$265K |
- |
| 2024-06-13 |
Gillies Hunter |
Chief Medical Officer |
情報に基づく売り |
6,000 |
$24.50 |
$147K |
5,602 |
| 2024-06-05 |
Santel Donald J |
Director |
RSU 付与（制限付株式） |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Ra Capital Management, L.p. |
10 Percent Owner |
RSU 付与（制限付株式） |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Iwicki Mark T |
Director |
RSU 付与（制限付株式） |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Dorval Allison |
Director |
RSU 付与（制限付株式） |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Dable Habib J |
Director |
RSU 付与（制限付株式） |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Resnick Joshua |
Director |
RSU 付与（制限付株式） |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Katabi Maha |
10 Percent Owner |
RSU 付与（制限付株式） |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-06-05 |
Grayzel David S. |
Director |
RSU 付与（制限付株式） |
12,500 |
$18.90 |
$236.25K |
12,500 |
| 2024-05-17 |
Gillies Hunter |
Chief Medical Officer |
情報に基づく売り |
86 |
$21.86 |
$1.88K |
5,602 |
| 2024-05-16 |
Noyes Timothy P |
Chief Executive Officer |
情報に基づく売り |
1,293 |
$21.92 |
$28.35K |
- |
| 2024-05-02 |
Verwijs Marinus |
Chief Technical Officer |
情報に基づく売り |
1,981 |
$21.02 |
$41.63K |
- |
| 2024-05-01 |
Noyes Timothy P |
Chief Executive Officer |
情報に基づく売り |
965 |
$20.87 |
$20.14K |
- |
| 2024-04-17 |
Gillies Hunter |
Chief Medical Officer |
オプション行使（売却） |
3,497 |
$1.74 |
$6.08K |
539 |
| 2024-04-17 |
Dake Benjamin T |
See Remarks |
情報に基づく売り |
68 |
$23.97 |
$1.63K |
1,291 |
| 2024-04-16 |
Noyes Timothy P |
Chief Executive Officer |
情報に基づく売り |
5,509 |
$24.94 |
$137.41K |
- |
| 2024-04-10 |
Eldridge George A |
See Remarks |
情報に基づく売り |
771 |
$27.56 |
$21.25K |
1,960 |
| 2024-04-09 |
Grayzel David S. |
Director |
情報に基づく売り |
11,882 |
$28.15 |
$334.48K |
14,502 |
| 2024-04-01 |
Noyes Timothy P |
Chief Executive Officer |
情報に基づく売り |
1,000 |
$31.95 |
$31.95K |
- |
| 2024-04-01 |
Eldridge George A |
See Remarks |
情報に基づく売り |
12,495 |
$31.23 |
$390.21K |
1,960 |
| 2024-04-01 |
Dake Benjamin T |
See Remarks |
情報に基づく売り |
3,325 |
$31.97 |
$106.32K |
1,291 |
| 2024-04-01 |
Verwijs Marinus |
Chief Technical Officer |
情報に基づく売り |
1,504 |
$30.00 |
$45.12K |
- |
| 2024-03-28 |
Gillies Hunter |
Chief Medical Officer |
情報に基づく売り |
9,000 |
$29.50 |
$265.5K |
3,251 |
| 2024-03-27 |
Dake Benjamin T |
See Remarks |
情報に基づく売り |
11,068 |
$27.97 |
$309.52K |
1,291 |
| 2024-03-25 |
Dake Benjamin T |
See Remarks |
情報に基づく売り |
3,432 |
$28.01 |
$96.12K |
1,291 |
| 2024-03-19 |
Verwijs Marinus |
Chief Technical Officer |
情報に基づく売り |
2,764 |
$26.46 |
$73.12K |
- |
| 2024-03-18 |
Gillies Hunter |
Chief Medical Officer |
情報に基づく売り |
613 |
$26.40 |
$16.18K |
3,251 |
| 2024-03-18 |
Dake Benjamin T |
See Remarks |
情報に基づく売り |
7,581 |
$26.48 |
$200.76K |
1,291 |
| 2024-03-13 |
Eldridge George A |
See Remarks |
情報に基づく売り |
2,016 |
$25.02 |
$50.44K |
1,960 |
| 2024-03-12 |
Eldridge George A |
See Remarks |
情報に基づく売り |
2,051 |
$25.05 |
$51.37K |
1,960 |
| 2024-03-11 |
Eldridge George A |
See Remarks |
情報に基づく売り |
10 |
$26.31 |
$263.05 |
1,960 |
| 2024-03-08 |
Eldridge George A |
See Remarks |
情報に基づく売り |
114 |
$25.00 |
$2.85K |
1,960 |
| 2024-03-07 |
Eldridge George A |
See Remarks |
情報に基づく売り |
22,386 |
$25.00 |
$559.69K |
1,960 |
| 2024-03-07 |
Gillies Hunter |
Chief Medical Officer |
情報に基づく売り |
8,975 |
$24.50 |
$219.89K |
3,251 |
| 2024-03-04 |
Dable Habib J |
Director |
RSU 付与（制限付株式） |
1,531 |
$22.49 |
$34.43K |
1,531 |
| 2024-02-23 |
Gillies Hunter |
Chief Medical Officer |
オプション行使（売却） |
511 |
$1.74 |
$889.14 |
3,014 |
| 2024-02-20 |
Gillies Hunter |
Chief Medical Officer |
情報に基づく売り |
898 |
$20.58 |
$18.48K |
3,251 |
| 2024-02-05 |
Niven Ralph |
Chief Scientific Officer |
情報に基づく売り |
4,600 |
$17.45 |
$80.25K |
1,609 |
| 2024-01-29 |
Noyes Timothy P |
Chief Executive Officer |
RSU 付与（制限付株式） |
200,000 |
$18.10 |
$3.62M |
200,000 |
| 2024-01-22 |
Niven Ralph |
Chief Scientific Officer |
RSU 付与（制限付株式） |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Eldridge George A |
See Remarks |
RSU 付与（制限付株式） |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Gillies Hunter |
Chief Medical Officer |
RSU 付与（制限付株式） |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Dake Benjamin T |
See Remarks |
RSU 付与（制限付株式） |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Verwijs Marinus |
Chief Technology Officer |
RSU 付与（制限付株式） |
66,586 |
$20.00 |
$1.33M |
66,586 |
| 2024-01-22 |
Pigot Timothy |
Chief Commercial Officer |
RSU 付与（制限付株式） |
66,586 |
$20.00 |
$1.33M |
66,586 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
